1. Home
  2. ELUT vs ZYXI Comparison

ELUT vs ZYXI Comparison

Compare ELUT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • ZYXI
  • Stock Information
  • Founded
  • ELUT 2015
  • ZYXI 1996
  • Country
  • ELUT United States
  • ZYXI United States
  • Employees
  • ELUT N/A
  • ZYXI N/A
  • Industry
  • ELUT Medical Specialities
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ELUT Health Care
  • ZYXI Health Care
  • Exchange
  • ELUT Nasdaq
  • ZYXI Nasdaq
  • Market Cap
  • ELUT 73.2M
  • ZYXI 66.5M
  • IPO Year
  • ELUT 2020
  • ZYXI N/A
  • Fundamental
  • Price
  • ELUT $1.81
  • ZYXI $2.49
  • Analyst Decision
  • ELUT Strong Buy
  • ZYXI Buy
  • Analyst Count
  • ELUT 2
  • ZYXI 3
  • Target Price
  • ELUT $8.00
  • ZYXI $6.00
  • AVG Volume (30 Days)
  • ELUT 25.1K
  • ZYXI 204.8K
  • Earning Date
  • ELUT 08-06-2025
  • ZYXI 07-24-2025
  • Dividend Yield
  • ELUT N/A
  • ZYXI N/A
  • EPS Growth
  • ELUT N/A
  • ZYXI N/A
  • EPS
  • ELUT N/A
  • ZYXI N/A
  • Revenue
  • ELUT $23,711,000.00
  • ZYXI $172,401,000.00
  • Revenue This Year
  • ELUT $20.10
  • ZYXI N/A
  • Revenue Next Year
  • ELUT $85.89
  • ZYXI $19.55
  • P/E Ratio
  • ELUT N/A
  • ZYXI N/A
  • Revenue Growth
  • ELUT N/A
  • ZYXI N/A
  • 52 Week Low
  • ELUT $1.61
  • ZYXI $1.66
  • 52 Week High
  • ELUT $5.24
  • ZYXI $10.62
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 45.88
  • ZYXI 56.22
  • Support Level
  • ELUT $1.72
  • ZYXI $1.99
  • Resistance Level
  • ELUT $1.96
  • ZYXI $2.47
  • Average True Range (ATR)
  • ELUT 0.15
  • ZYXI 0.15
  • MACD
  • ELUT 0.01
  • ZYXI 0.04
  • Stochastic Oscillator
  • ELUT 24.13
  • ZYXI 91.46

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: